1. Home
  2. LXRX vs NOA Comparison

LXRX vs NOA Comparison

Compare LXRX & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • NOA
  • Stock Information
  • Founded
  • LXRX 1995
  • NOA 1953
  • Country
  • LXRX United States
  • NOA Canada
  • Employees
  • LXRX N/A
  • NOA N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • LXRX Health Care
  • NOA Consumer Staples
  • Exchange
  • LXRX Nasdaq
  • NOA Nasdaq
  • Market Cap
  • LXRX 428.8M
  • NOA 478.5M
  • IPO Year
  • LXRX 2000
  • NOA 2006
  • Fundamental
  • Price
  • LXRX $1.13
  • NOA $13.65
  • Analyst Decision
  • LXRX Buy
  • NOA
  • Analyst Count
  • LXRX 5
  • NOA 0
  • Target Price
  • LXRX $3.23
  • NOA N/A
  • AVG Volume (30 Days)
  • LXRX 1.8M
  • NOA 195.9K
  • Earning Date
  • LXRX 11-11-2025
  • NOA 10-29-2025
  • Dividend Yield
  • LXRX N/A
  • NOA 2.54%
  • EPS Growth
  • LXRX N/A
  • NOA N/A
  • EPS
  • LXRX N/A
  • NOA 0.87
  • Revenue
  • LXRX $58,432,000.00
  • NOA $919,386,154.00
  • Revenue This Year
  • LXRX N/A
  • NOA $16.06
  • Revenue Next Year
  • LXRX N/A
  • NOA $3.84
  • P/E Ratio
  • LXRX N/A
  • NOA $15.46
  • Revenue Growth
  • LXRX 1504.83
  • NOA 14.15
  • 52 Week Low
  • LXRX $0.28
  • NOA $12.12
  • 52 Week High
  • LXRX $2.18
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 50.83
  • NOA 46.54
  • Support Level
  • LXRX $1.03
  • NOA $13.10
  • Resistance Level
  • LXRX $1.15
  • NOA $13.77
  • Average True Range (ATR)
  • LXRX 0.06
  • NOA 0.31
  • MACD
  • LXRX -0.01
  • NOA 0.11
  • Stochastic Oscillator
  • LXRX 50.00
  • NOA 83.33

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: